Abstract
Although previous studies attributed a pro-survival role to USP9X in human cancer, how USP9X affects B-cell acute lymphoblastic leukemia (B-ALL) remains unclear. Here, we found that USP9X is overexpressed in B-ALL cell lines and human patients. We investigated the role of USP9X in B-ALL and found that USP9X knockdown significantly reduced leukemic cell growth and increased spontaneous apoptosis, thereby improving survival in immunodeficient mice. These effects are partially mediated by the intrinsic apoptotic pathway, as we found that USP9X-knockdown leukemic cells displayed MCL1 down-regulation, with decreased BCL-2/BCL-XL levels and increased BAX levels. In addition, we demonstrated that USP9X inhibition negatively regulates mTORC1 activity toward its substrate S6K1. Clinically, USP9X inhibition sensitized glucocorticoid-resistant ALL cells to prednisolone; this observation reveals a potential avenue for improving the treatment of drug-resistant relapses. Collectively, our findings suggest that the combination of USP9X targeting and glucocorticoids treatment has attractive utility in B-ALL. This approach represents a potential strategy for promising combination therapies for lymphoid malignancies.
References
Aug 29, 1998·The Journal of Cell Biology·S TayaK Kaibuchi
Jan 5, 2000·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·S TayaK Kaibuchi
Jan 17, 2002·Leukemia Research·H Elizabeth BroomeNicholas M Dean
Aug 6, 2004·The New England Journal of Medicine·Amy HollemanWilliam E Evans
Oct 29, 2004·The Journal of Biological Chemistry·Marc T AbramsEric Wickstrom
Jul 30, 2005·Biochemical and Biophysical Research Communications·Peng WuDing Ma
Dec 3, 2005·Science·Queenie P VongYixian Zheng
Mar 25, 2008·Lancet·Ching-Hon PuiA Thomas Look
Jan 13, 2009·Cell·Sirio DupontStefano Piccolo
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Dec 8, 2009·Blood·Ronald W StamRob Pieters
Jan 15, 2010·Nature Medicine·Matthew R JanesDavid A Fruman
Feb 24, 2010·The Journal of Experimental Medicine·Xiaoyuan HuangJianfeng Zhou
Oct 23, 2010·Molecular Cell·Shomit SenguptaDavid M Sabatini
Nov 5, 2010·Blood·Serena PillozziAnnarosa Arcangeli
Jan 21, 2011·Blood·Hanshi SunNicholas J Donato
Jul 29, 2011·Leukemia Research·Shuji SaiKaren E Chapman
Sep 13, 2011·Biochemical and Biophysical Research Communications·Patricia Gomez-BougieMartine Amiot
Jan 28, 2012·Leukemia·J A P Spijkers-HagelsteinR W Stam
May 1, 2012·The Journal of Biological Chemistry·Pooja AgrawalRobert E Hughes
Aug 16, 2012·Cancer Biology & Therapy·Na WangJianfeng Zhou
Nov 23, 2012·BMC Cancer·Chander PeddaboinaXiaobo Cao
Jul 12, 2013·Leukemia & Lymphoma·Craig A Portell, Anjali S Advani
Citations
Oct 22, 2011·PloS One·Sanja AveicGiuseppe Basso
Oct 12, 2012·PloS One·Shanna K NifoussiRuth W Craig
May 15, 2013·PloS One·Jesse L CoxAngie Rizzino
Feb 27, 2013·PloS One·Cagri BodurHuveyda Basaga
Jul 19, 2013·PloS One·Shane StegemanStephen A Wood
Feb 2, 2011·PloS One·Chiara LuiseStefano Confalonieri
Oct 24, 2014·PLoS Pathogens·Young Bong Choi, Edward William Harhaj
Sep 7, 2016·Oncogene·J IzrailitM Reedijk
May 20, 2016·PloS One·Anna PolakPrzemysław Juszczyński
Dec 30, 2016·Genes, Chromosomes & Cancer·Lisa J RussellChristine J Harrison
Dec 12, 2017·Nucleic Acids Research·Zengxia LiYongjun Dang
Feb 13, 2016·Oncotarget·Georg Karpel-MasslerMarkus D Siegelin
Sep 8, 2016·Oncotarget·Jean-François SpinellaDaniel Sinnett
Jan 14, 2020·Annals of the New York Academy of Sciences·Tingting LuJishi Wang
Jul 18, 2020·Cancers·Antonella Di CostanzoLucia Altucci
May 4, 2017·Proceedings of the National Academy of Sciences of the United States of America·Omer SchwartzmanShai Izraeli
Sep 5, 2020·Nature Cancer·Robert J AutryWilliam E Evans
Mar 7, 2020·Trends in Immunology·Blanca T Gutierrez-DiazPanagiotis Ntziachristos
Aug 30, 2021·Biomarker Research·Hu LeiYingli Wu